Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
TIP26-314: Targeting Macrophage Migration Inhibitory Factor: A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: May 01, 2026
TIP26-314: Targeting Macrophage Migration Inhibitory Factor: A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 30, 2026
Phase 2 study of regorafenib in patients with progressive glioblastoma after failure of bevacizumab.
Phase 2 study of regorafenib in patients with progressive glioblastoma after failure of bevacizumab.
Journal: Neuro-oncology advances
Published: October 24, 2025
Showing 1-3 of 3
Last Updated: 09/26/2026